Erasca (ERAS): Erasca Foundation files to sell 8,333 donated shares

Rhea-AI Filing Summary

Erasca Foundation has filed to sell common stock of Erasca, Inc. under a Form 144 notice. The planned sale covers 8,333 shares of common stock through Merrill Lynch, with an aggregate market value of $157,637.52, and is expected on July 21, 2026 on NASDAQ. The Foundation previously received 10,193,557 shares as a donation from Erasca, Inc. on July 20, 2021 and has already sold 8,333 shares on May 15, 2026 for $84,528.29 and another 8,333 shares on June 15, 2026 for $117,476.95.

Key Figures

Planned shares to be sold: 8,333 shares Aggregate market value of planned sale: $157,637.52 Shares sold May 15, 2026: 8,333 shares +4 more

7 metrics

Planned shares to be sold 8,333 shares Common stock sale expected July 21, 2026 under Form 144

Aggregate market value of planned sale $157,637.52 Value of 8,333 Erasca, Inc. common shares to be sold

Shares sold May 15, 2026 8,333 shares Common stock sold for $84,528.29 during past 3 months

Proceeds May 15, 2026 sale $84,528.29 Sale of 8,333 shares of Erasca, Inc. common stock

Shares sold June 15, 2026 8,333 shares Common stock sold for $117,476.95 during past 3 months

Proceeds June 15, 2026 sale $117,476.95 Sale of 8,333 shares of Erasca, Inc. common stock

Donation from Erasca, Inc. 10,193,557 shares Common stock donated to Erasca Foundation on July 20, 2021

Key Terms

Form 144, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"Erasca Foundation has filed to sell common stock of Erasca, Inc. under a Form 144 notice."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 07/20/2021 | Donation | Erasca, Inc."

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months Erasca Foundation 3115 MERRYFIELD ROW STE 300"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/21/2026 - 04:05 PM Accepted by SEC EDGAR 07/21/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What does Erasca (ERAS) disclose in this Form 144 filing?

The filing shows Erasca Foundation intends to sell 8,333 shares of Erasca, Inc. common stock. The planned sale, valued at $157,637.52, is expected to occur on July 21, 2026 through Merrill Lynch on NASDAQ.

How many Erasca (ERAS) shares is Erasca Foundation planning to sell now?

Erasca Foundation plans to sell 8,333 shares of Erasca, Inc. common stock. The aggregate market value of these shares is reported as $157,637.52, with the transaction expected to take place on July 21, 2026 on NASDAQ.

What Erasca (ERAS) share sales has Erasca Foundation made in the past 3 months?

The Foundation reports two sales of 8,333 shares each. One occurred on May 15, 2026 for $84,528.29, and another on June 15, 2026 for $117,476.95, both involving Erasca, Inc. common stock.

How did Erasca Foundation obtain its Erasca (ERAS) shares?

Erasca Foundation received 10,193,557 shares of Erasca, Inc. common stock via a donation. This donation occurred on July 20, 2021 from Erasca, Inc., providing the share pool from which subsequent sales are made.

Which broker is handling the planned Erasca (ERAS) share sale for Erasca Foundation?

The planned sale of 8,333 shares of Erasca, Inc. common stock will be handled by Merrill Lynch. The filing lists Merrill Lynch with an aggregate market value of $157,637.52 and execution on NASDAQ on July 21, 2026.

What is the significance of Form 144 for Erasca (ERAS) shareholders?

Form 144 indicates intent to sell restricted or control securities, here by Erasca Foundation. It does not guarantee the sale will occur but discloses the planned 8,333-share transaction and recent sales, improving transparency around potential share supply.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 6002 El Tordo PO Box 7297 Rancho Santa Fe CA 92067	8333	157637.52	310984542	07/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2021	Donation	Erasca, Inc.			10193557	07/20/2021	Donation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	06/15/2026	8333	117476.95
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	05/15/2026	8333	84528.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)